| Literature DB >> 24885661 |
Dave K Berger1, Maryke Carstens, Jeanne N Korsman, Felix Middleton, Frederik J Kloppers, Pangirayi Tongoona, Alexander A Myburg.
Abstract
BACKGROUND: Gray leaf spot (GLS) is a globally important foliar disease of maize. Cercospora zeina, one of the two fungal species that cause the disease, is prevalent in southern Africa, China, Brazil and the eastern corn belt of the USA. Identification of QTL for GLS resistance in subtropical germplasm is important to support breeding programmes in developing countries where C. zeina limits production of this staple food crop.Entities:
Mesh:
Year: 2014 PMID: 24885661 PMCID: PMC4059882 DOI: 10.1186/1471-2156-15-60
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
Figure 1Distribution of average GLS disease scores in the 145 RILs of the CML444 X SC Malawi population in each of the environments. The GLS disease scores on a 1-9 scale from resistant to susceptible are shown on the x-axis, and the number of RILs with each disease score is plotted on the y-axis and written above each column. The GLS disease scores for CML444 (♦) and SC Malawi (▲) are shown on the x-axis. The environments were: A-C, Redgates 2008, 2009, 2010, respectively; D-F, Ukalinga 2008 (planted 29 Nov 2007), Ukalinga 2008 (planted 19 Dec 2007), Ukalinga 2009, respectively; G, Hildesheim 2009; H-I, Baynesfield 2009, 2010, respectively; J-K Cedara 2008, 2009, respectively.
Analysis of variance of gray leaf spot (GLS) disease scores from a population consisting of 145 RILs from a CML444 X SC Malawi cross scored over eleven environments in KwaZulu-Natal, South Africa
| Environmenta | 10 | 5142 | 514 | 101 | < 0.001* |
| Replications within environment | 2 | 209 | 11 | 12 | < 0.001* |
| Genotype | 144 | 3972 | 28 | 31 | < 0.001* |
| Genotype x environment | 1437 | 2052 | 1.4 | 1.6 | < 0.001* |
| Residuals | 2727 | 2413 | 0.9 |
aThe RILs were planted in a randomized block with two or three replicates for each environment.
bDegree of freedom.
cSum of squares.
dMean square.
*Significant at P < 0.001.
Figure 2Q-Map 2.0 - Genetic linkage map (167 markers) from the RIL population (n = 145) derived from the parental lines CML 444 and SC Malawi. Each marker position (cM) and marker name are shown on the left and right of each chromosome, respectively. Markers added to the map obtained from Messmer et al.[33] are indicated by *. QTL for days to anthesis (white bars), GLS resistance per field trial (black bars) and joint QTL for GLS resistance (cross hatch bars) are shown on the right of relevant chromosomes (1-LOD intervals i.e. 95% confidence intervals). The 2-LOD intervals (99% confidence intervals) for each QTL are indicated by lines on each side of the 1-LOD intervals.
QTL for gray leaf spot (GLS) resistance and days to anthesis (DTA) identified in the CML444 X SC Malawi RIL population$
| 1 | 1.10 | umc147b | 264.7 - 281.0 | 264.3 - 285.7 | 3.39 | 10.1 | -0.460 | CML | 1C_GLS |
| 1 | 1.10 | umc147b | 270.9 - 285.6 | 267.5 - 289.7 | 3.23 | 6.4 | -0.278 | CML | 1G_GLS |
| 3 | 3.02/3.03 | bnlg1447 | 29.6 - 46.2 | 25.3 - 50.1 | 2.95 | 8.5 | -0.409 | CML | 3H_GLS |
| 3 | 3.09 | bnlg1182 | 201.8 - 219.6 | 207.9 - 219.6 | 4.55 | 13.0 | -0.472 | CML | 3F_GLS |
| 4 | 4.01 | umc1017 | 0.0 - 8.2 | 0.0 - 13.3 | 3.14 | 8.0 | -0.252 | CML | 4K_GLS |
| 4 | 4.08 | umc15a | 121.9 - 133.8 | 116.5 - 136.6 | 4.78 | 10.9 | -0.364 | CML | 4G_GLS |
| 4 | 4.08 | umc15a | 122.6 - 132.9 | 120.9 - 136.0 | 4.55 | 12.8 | -0.551 | CML | 4E_GLS |
| 4 | 4.08 | umc15a | 122.9 - 136.1 | 120.4 - 140.5 | 3.59 | 8.9 | -0.336 | CML | 4B_GLS |
| 4 | 4.08 | csu11b | 127.9 - 139.3 | 127.9 - 142.3 | 3.92 | 12.0 | -0.497 | CML | 4J_GLS |
| 6 | 6.06 | umc1424 | 141.0 - 151.7 | 135.3 - 154.7 | 4.92 | 21.8 | 0.626 | SC | 6F_GLS |
| 6 | 6.06/6.07 | umc36 | 142.7 - 160.5 | 139.2 - 164.3 | 3.29 | 13.0 | 0.504 | SC | 6H_GLS |
| 6 | 6.06/6.07 | umc36 | 142.3 - 161.4 | 139.0 - 162.3 | 2.95 | 13.8 | 0.335 | SC | 6K_GLS |
| 6 | 6.06/6.07 | umc36 | 147.3 - 166.1 | 143.7 - 174.0 | 3.64 | 13.7 | 0.584 | SC | 6E_GLS |
| 6 | 6.06/6.07 | umc36 | 147.5 - 162.1 | 143.1 - 169.6 | 5.00 | 10.2 | 0.362 | SC | 6G_GLS |
| 6 | 6.06/6.07 | umc36 | 150.7 - 162.0 | 147.7 - 168.5 | 4.61 | 10.7 | 0.232 | SC | 6I_GLS |
| 6 | 6.06/6.07 | umc36 | 148.3 - 163.9 | 143.2 - 174.4 | 3.38 | 9.3 | 0.451 | SC | 6J_GLS |
| 7 | 7.02 | umc1393 | 10.0 - 28.7 | 9.0 - 30.7 | 3.16 | 10.2 | 0.467 | SC | 7C_GLS |
| 7 | 7.02 | umc1393 | 20.4 - 29.7 | 20.1 - 30.8 | 3.31 | 10.4 | 0.218 | SC | 7I_GLS |
| 7 | 7.02/7.03 | bnlg1808 | 22.1 - 36.5 | 20.4 - 40.5 | 3.00 | 9.0 | 0.273 | SC | 7K_GLS |
| 7 | 7.02/7.03 | bnlg1808 | 34.4 - 41.1 | 33.0 - 43.0 | 4.67 | 13.4 | 0.341 | SC | 7A_GLS |
| 7 | 7.02/7.03 | bnl15.21 | 30.8 - 42.8 | 30.8 - 44.6 | 3.16 | 9.4 | 0.446 | SC | 7J_GLS |
| 7 | 7.04 | bnl14.07 | 72.2 - 86.3 | 67.2 - 87.4 | 3.26 | 10.0 | 0.425 | SC | 7F_GLS |
| 9 | 9.04/9.05 | umc1231 | 83.0 - 97.3 | 75.6 - 97.6 | 3.31 | 10.7 | -0.317 | CML | 9A1_GLS |
| 9 | 9.04/9.05 | umc1231 | 92.9 - 101.3 | 77.8 - 105.5 | 3.70 | 9.2 | -0.435 | CML | 9F1_GLS |
| 9 | 9.06 | umc1733 | 115.0 - 122.8 | 110.7 - 124.5 | 3.40 | 7.6 | 0.398 | SC | 9H_GLS |
| 9 | 9.06 | umc1733 | 119.8 - 123.6 | 119.8 - 124.7 | 4.51 | 10.1 | 0.482 | SC | 9F2_GLS |
| 9 | 9.06 | umc1733 | 120.3 - 123.6 | 120.0 - 124.4 | 6.65 | 17.8 | 0.443 | SC | 9A2_GLS |
| 10 | 10.2 | umc1337 | 23.4 - 40.5 | 16.6 - 45.5 | 2.99 | 6.3 | -0.283 | CML | 10G1_GLS |
| 10 | 10.06/10.07 | bnl7.49a | 114.0 - 127.9 | 110.9 - 129.8 | 4.53 | 13.5 | -0.509 | CML | 10H_GLS |
| 10 | 10.06/10.07 | bnl7.49a | 113.4 - 129.2 | 108.7 - 129.9 | 4.52 | 12.5 | -0.391 | CML | 10G2_GLS |
| 4 | 4.08 | umc15a | 122.3 - 134.4 | 120.4 - 138.0 | 3.90 | 10.6 | -0.275 | CML | 4_GLS* |
| 6 | 6.06/6.07 | umc36 | 148.8 - 161.4 | 146.2 - 167.2 | 6.09 | 20.9 | 0.392 | SC | 6_GLS* |
| 1 | 1.07 | dupssr12 | 189.7 - 202.0 | 187.5 - 217.2 | 4.73 | 14 | 1.1399 | SC | 1_DTA# |
| 4 | 4.09 | npi593a | 141.6 - 149.8 | 138.0 - 153.1 | 4.04 | 10 | 0.9455 | SC | 4_DTA# |
aMaize chromosome.
bChromosome bin location of QTL (1-LOD (i.e. 95% confidence) interval) based on shared markers with the IBM2005 neighbours frame map.
cPeak marker refers to marker on QMap 2.0 that is closest to the QTL peak.
dRange in cM that defines 1-LOD interval of QTL.
eRange in cM that defines 2-LOD interval of QTL.
fLog of odds (LOD) value at position of QTL peak.
gPhenotypic variance explained by the QTL (expressed as percentage).
hAdditive effect of QTL. For GLS disease ratings, this is based on the one to nine scale employed. For days to anthesis, this is based on days. Positive values indicate that the allele for resistance or early anthesis was derived from SC Malawi.
iParental allele associated with increased GLS resistance or earlier anthesis CML = CML444; SC = SC Malawi.
jQTL name. First number indicates maize chromosome number whereas letter denotes field trial as described in Figure 1. Subsequent numbers differentiate more than one QTL identified on the same chromosme in the same field trial. GLS represent QTL for GLS resistance whereas DTA indicate QTL for days to anthesis.
*Joint GLS QTL calculated from the mean z-scores of the least square means of the GLS disease scores from the eleven environments.
#DTA QTL were identified using DTA data from an independent field trial at Redgates 2010.
$GLS QTL were identified using QMap2.0 and GLS disease data from each of eleven environments in KwaZulu-Natal, South Africa. DTA QTL were identified using QMap2.0 and DTA data from an independent field trial at Redgates farm, KwaZulu-Natal, South Africa.